IDH2 and central nervous system cancer: Notably, in contrast to other IDH‐mutant gliomas, where O‐6‐methylguanine‐DNA methyltransferase (MGMT) promoter hypermethylation is a common feature in majority of the cases, PMMRDIA shows the highest frequency of unmethylated MGMT promotor [14].